Comorbidities, medications and depressive symptoms in patients with restless legs syndrome and migraine

被引:10
作者
Ferreira, Karen S. [1 ]
Eckeli, Alan [1 ]
Dach, Fabiola [1 ]
Speciali, Jose G. [1 ]
机构
[1] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Neurosci, Sao Paulo, Brazil
关键词
migraine; restless legs syndrome; comorbidity; medication; depression; SYNDROME RLS; POPULATION; PREVALENCE; EPIDEMIOLOGY; DIAGNOSIS; DOPAMINE; QUALITY; IMPACT;
D O I
10.1590/S0004-282X2013005000007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: The pathophysiology of migraine and restless legs syndrome (RLS) seems to involve inherited mechanism and dysfunction of the dopaminergic system. Previous articles have shown that the frequency of RLS is higher in migraine patients than in controls. We conducted a study to evaluate comorbidities, medication used and depressive symptoms that can explain the relation between migraine and RLS. Methods: A case-control study was performed in which patients with migraine (n=72) and a control group without migraine (n=72) were interviewed. Data including RLS diagnosis, depressive symptoms, comorbidities and drugs used were evaluated. Results: There was a significant association between migraine and RLS (p=0.01), but comorbidities such as diabetes, hypertension, anemia and drugs used did not explain this association. Depression scores, as measured by the Beck Depression Inventory, were higher in migraine patients with RLS (p=0.04). Conclusion: No specific factors explaining the association between migraine and RLS were found. Symptoms of depression were more frequent in patients with migraine and RLS.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 31 条
  • [1] Dopamine and migraine: biology and clinical implications
    Akerman, S.
    Goadsby, P. J.
    [J]. CEPHALALGIA, 2007, 27 (11) : 1308 - 1314
  • [2] Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
    Allen, RP
    Picchietti, D
    Hening, WA
    Trenkwalder, C
    Walters, AS
    Montplaisi, J
    [J]. SLEEP MEDICINE, 2003, 4 (02) : 101 - 119
  • [3] Restless legs syndrome prevalence and impact - REST general population study
    Allen, RP
    Walters, AS
    Montplaisir, J
    Hening, W
    Myers, A
    Bell, TJ
    Ferini-Strambi, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) : 1286 - 1292
  • [4] A Novel Locus for Restless Legs Syndrome on Chromosome 13q
    Balaban, Hatice
    Bayrakli, Fatih
    Kartal, Ugur
    Pinarbasi, Ergun
    Topaktas, Suat
    Kars, Hamit Zafer
    [J]. EUROPEAN NEUROLOGY, 2012, 68 (02) : 111 - 116
  • [5] Becker WJ, 2007, CAN J NEUROL SCI, V34, pS3
  • [6] Dopamine inhibits trigeminovascular transmission in the rat
    Bergerot, Astrid
    Storer, Robin J.
    Goadsby, Peter J.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (03) : 251 - 262
  • [7] Chen PK, 2010, J NEUROL NEUROSUR PS, V81, P524, DOI 10.1136/jnnp.2009.191684
  • [8] High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?
    Cologno, Daniela
    Cicarelli, Giulio
    Petretta, Vittorio
    d'Onofrio, Florindo
    Bussone, Gennaro
    [J]. NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 1) : S166 - S168
  • [9] Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
    Connor, JR
    Boyer, PJ
    Menzies, SL
    Dellinger, B
    Allen, RP
    Ondo, WG
    Earley, CJ
    [J]. NEUROLOGY, 2003, 61 (03) : 304 - 309
  • [10] Restless legs syndrome and primary headaches: a clinical study
    d'Onofrio, Florindo
    Bussone, Gennaro
    Cologno, Daniela
    Petretta, Vittorio
    Buzzi, Maria Grazia
    Tedeschi, Gioacchino
    Bonavita, Vincenzo
    Cicarelli, Giulio
    [J]. NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 1) : S169 - S172